Infant cortisol response after prolonged antenatal prednisolone treatment
- 22 November 2004
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 111 (12), 1471-1474
- https://doi.org/10.1111/j.1471-0528.2004.00288.x
Abstract
Prednisolone is widely used to treat medical conditions in pregnancy, despite the lack of long term safety studies on infants. Animal studies have shown that antenatal glucocorticoid treatment can cause in utero growth restriction and up-regulation of the offsprings' hypathalamic–pituitary–adrenal axis. We recruited women treated antenatally with prednisolone, and followed 12 of the infants up to four months, using routine infant vaccinations as a stressor. Birthweights were similar to controls (n= 289, uncomplicated, singleton term pregnancies), as were infants' baseline and stress-induced cortisol levels. Mothers rated their infants as less difficult and more adaptable than controls. This study provides initial reassurance about the safety of prednisolone in pregnancy.This publication has 7 references indexed in Scilit:
- Neonatal effects and serum cortisol levels after multiple courses of maternal corticosteroidsObstetrics & Gynecology, 1997
- Pituitary-Adrenal Response in Preterm Very Low Birth Weight Infants after Treatment with Antenatal CorticosteroidsJournal of Clinical Endocrinology & Metabolism, 1997
- The Effects of Birth Condition on Infants' Cortisol Response to StressPEDIATRICS, 1995
- Steroids in pregnancyCurrent Obstetrics & Gynaecology, 1994
- Pregnancy in inflammatory bowel disease: Effect of sulfasalazine and corticosteroids on fetal outcomeGastroenterology, 1981
- Pregnancy in Patients on Long-Term Corticosteroid TherapyScottish Medical Journal, 1967